Clinical Trials Administrator Archives – November 1, 2007
November 1, 2007
View Issues
-
Knowing site metrics will help you stay competitive as industry changes
The pharmaceutical research industry's productivity is declining and cost is rising, a dangerous combination that is the force behind changes in how drug company sponsors do research. -
Atlanta research company shares tips on promoting quality for growth
Adhering to quality principles and building internal controls for compliance are key factors behind the growth of a successful Southeastern clinical research site. -
Merck director discusses company's strategies for clinical research success
CTA: The Tufts Center for the Study of Drug Development has identified Merck as one of the five fastest drug developers for the most recent time period studied (2000-2005). -
Researchers and physicians have different obligations to patients
Health care patients, the general public, and sometimes even physicians and researchers at times misconstrue the relationship investigators have to research participants, an ethics expert says. -
History of informed consent might predict trend of greater protection
Investigators and clinical research professionals who have worked in the clinical trial industry for two or more decades may find themselves astonished by current controversies and debates over informed consent of human subjects. -
Build human subject protection education into research office practices
When the federal government suspended human subjects research at Virginia Commonwealth University of Richmond, VA, in 2000, the institution's leaders turned the bad news into an opportunity to create a new and improved human subjects research program. -
2007 Salary Survey Results: New jobs are opening up and existing ones compete for workers in clinical research industry
It's a very good time to be an experienced clinical trials professional, according to experts and the 2007 Clinical Trials Administrator's salary survey.